Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis

<div>IGF2BP3 expression levels in pancancer. (a) Relative expression of IGF2BP3 in pancancer and normal tissues, based on the Oncomine database; (b) relative expression of IGF2BP3 in pancancer and normal tissues, based on the TIMER database.</div>

Disease Markers

fig1

Figure 1

Figure 1: Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis 